← Open Payments lookup

PETER YAMAMOTO: Open Payments

NPI 1386796589 · WAIANAE, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,575 in 41 payments from 11 companies in 2025. Trend: 2023 $2,373 · 2024 $2,384 · 2025 $1,575

Food & beverage: $1,575
CompanyPaymentsAmount
Alkermes, Inc.12$421
Janssen Pharmaceuticals, Inc11$323
Teva Pharmaceuticals USA, Inc.5$224
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$145
Otsuka America Pharmaceutical, Inc.1$125
Janssen Scientific Affairs, LLC1$94
ABBVIE INC.3$81
Neurocrine BioSciences, Inc.1$72
E.R. Squibb & Sons, L.L.C.2$38
Vanda Pharmaceuticals Inc.1$30

Products named: INVEGA SUSTENNA, ARISTADA, UZEDY, CAPLYTA, ABILIFY MAINTENA, LYBALVI, VRAYLAR, INGREZZA.

Industry payments across HI — which companies pay providers there.